H. Mulec

发表

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Walker, R. Collins, V. Fuster, 1994 .

Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease.

A. Ricksten, H. Mulec, O. Samuelsson, 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 2006, Kidney international.

Complex apolipoprotein B-containing lipoprotein particles are associated with a higher rate of progression of human chronic renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 1998, Journal of the American Society of Nephrology : JASN.

Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.

H. Wedel, H. Mulec, O. Samuelsson, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure

H. Wedel, H. Mulec, O. Samuelsson, 1996 .

Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy.

G. Nyberg, H. Mulec, M. Aurell, 1990, BMJ.

Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure.

H. Wedel, H. Mulec, O. Samuelsson, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The Plasma Levels of Homocysteine Are Elevated in Moderate Renal Insufficiency but Do Not Predict the Rate of Progression

H. Mulec, O. Samuelsson, P. Attman, 1999, Nephron.

Relation between serum cholesterol and diabetic nephropathy

H. Mulec, S. Björck, S. Johnson, 1990, The Lancet.

Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group.

H. Mulec, J. Dickinson, R. Larsson, 1998, Scandinavian journal of urology and nephrology.

Latent overhydration and nocturnal hypertension in diabetic nephropathy

G. Nyberg, G. Blohmé, H. Mulec, 1995, Diabetologia.

Captopril treatment of hypertension and renal failure in systemic lupus erythematosus.

H. Mulec, G. Westberg, H. Herlitz, 1984, Nephron.

Influence of Severe Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Ximelagatran and Subcutaneous Melagatran

H. Mulec, O. Samuelsson, P. Attman, 2003, Clinical pharmacokinetics.

Renal protective effect of enalapril in diabetic nephropathy.

H. Mulec, G. Nordén, M. Aurell, 1992 .

Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis.

H. Mulec, A. Gutierrez, K. Gröntoft, 1985, Scandinavian journal of urology and nephrology.

Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Captopril treatment in hypertensive dialysis patients.

H. Mulec, H. Herlitz, M. Aurell, 1982, Scandinavian journal of urology and nephrology.

Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy.

G. Nyberg, H. Mulec, H. Herlitz, 1986, British medical journal.

Acute Renal Failure after Intoxication with Cortinarius Mushrooms

H. Mulec, J. Ahlmén, J. Holmdahl, 1984, Human toxicology.

Cholesterol: a renal risk factor in diabetic nephropathy?

O. Wiklund, O. Wiklund, H. Mulec, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS AFTER HYDRALAZINE

H. Mulec, G. Westberg, S. Björck, 1983, The Lancet.

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.

H. Mulec, O. Samuelsson, P. Attman, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.

G. Blohmé, H. Mulec, S. Björck, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of gemfibrozil on lipoprotein abnormalities in chronic renal insufficiency: a controlled study in human chronic renal disease.

H. Mulec, O. Samuelsson, P. Attman, 1997, Nephron.

Long-term enalapril treatment in diabetic nephropathy.

H. Mulec, S. Björck, S. Johnsen, 1994, Kidney international. Supplement.

RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS AFTER HYDRALAZINE

H. Mulec, G. Westberg, S. Björck, 1983, The Lancet.